Moderna expects to have mNEXSPIKE available for eligible populations in the U.S. for the 2025-2026 respiratory virus season, alongside Spikevax and mRESVIA ®, the Company's approved respiratory ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

Over the last decade, drug overdose deaths in Missouri and Kansas have continued to climb every year, often by double-digit percentages. But in 2023, that changed as overdose deaths declined by at ...